Thomas Bachelot

30PUBLICATIONS
185CO-AUTHORS
Predictive and prognostic markersMolecular targetsForensic epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Nov 10, 2025
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.

Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria

|Sep 29, 2025
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC Trial.

Jose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Aug 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

François-Clément Bidard, Grégoire Gessain, Thomas Bachelot

|Jun 30, 2025
Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach.

Anne-Laure Vitte, Florent Chuffart, Emmanuelle Jacquet

Pageof 5

Frequent Collaborators

7 joint publications

Olivier Trédan

7 joint publications

Fabrice Andre

5 joint publications

Armelle Dufresne

4 joint publications

Jean-Sébastien Frenel